Trailhead Biosystems is at the forefront of iPSC-derived cell innovation. Our advanced HD-DoE™ platform empowers researchers to overcome the limitations of primary cells, providing consistent, scalable, and affordable iPSC-based solutions. Whether it's through custom iPSC production, developing new cell types, or partnering for large-scale projects, we are committed to driving advancements in cellular research. Together with our collaborators in biotech, we're not just creating cells; we're reshaping the future of medicine.